Prevalence of underlying diseases in died cases of COVID-19: A systematic review and meta-analysis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prevalence of underlying diseases in died cases of COVID-19: A systematic review and meta-analysis
Authors
Keywords
COVID 19, SARS CoV 2, Epidemiology, Death rates, Diabetes mellitus, Publication ethics, Hypertension, Virus testing
Journal
PLoS One
Volume 15, Issue 10, Pages e0241265
Publisher
Public Library of Science (PLoS)
Online
2020-10-24
DOI
10.1371/journal.pone.0241265
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
- (2020) Qiurong Ruan et al. INTENSIVE CARE MEDICINE
- Asthma and COVID‐19: is asthma a risk factor for severe outcomes?
- (2020) Sebastian L. Johnston ALLERGY
- Cardiovascular disease as a biomarker for an increased risk of COVID-19 infection and related poor prognosis
- (2020) Nicola Ielapi et al. Biomarkers in Medicine
- Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 (COVID-19) in Wuhan, China
- (2020) Yan Deng et al. CHINESE MEDICAL JOURNAL
- COVID-19 and diabetes: Is metformin a friend or foe?
- (2020) Francesco Ursini et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis
- (2020) Wei-jie Guan et al. EUROPEAN RESPIRATORY JOURNAL
- Kidney diseases in the time of COVID-19: major challenges to patient care
- (2020) Hamid Rabb JOURNAL OF CLINICAL INVESTIGATION
- Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study
- (2020) Kunyu Yang et al. LANCET ONCOLOGY
- Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis
- (2020) Jaber S. Alqahtani et al. PLoS One
- Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Mingli Yuan et al. PLoS One
- Impact of Fundamental Diseases on Patients With COVID-19
- (2020) Yiguang Chen et al. Disaster Medicine and Public Health Preparedness
- Potential Benefits and Harms of Novel Antidiabetic Drugs During COVID-19 Crisis
- (2020) Maria Mirabelli et al. International Journal of Environmental Research and Public Health
- Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
- (2020) Chaomin Wu et al. JAMA Internal Medicine
- Epidemiological analysis of the early 38 fatalities in Hubei, China, of the coronavirus disease 2019
- (2020) Yifei Chen et al. Journal of Global Health
- Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020
- (2020) et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Clinical characteristics and outcomes of patients with severe covid-19 with diabetes
- (2020) Yongli Yan et al. BMJ Open Diabetes Research & Care
- A comprehensive review of COVID-19 characteristics
- (2020) Hanie Esakandari et al. BIOLOGICAL PROCEDURES ONLINE
- Epidemiological and clinical features of 2019 novel coronavirus diseases (COVID-19) in the South of Iran
- (2020) Reza Shahriarirad et al. BMC INFECTIOUS DISEASES
- Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study
- (2020) Mohamad Nikpouraghdam et al. JOURNAL OF CLINICAL VIROLOGY
- COVID-19—a very visible pandemic
- (2020) David N Durrheim et al. LANCET
- Risk factors for death in 1859 subjects with COVID-19
- (2020) Lei Chen et al. LEUKEMIA
- Clinical features of fatalities in patients with COVID-19
- (2020) Ya-Jun Sun et al. Disaster Medicine and Public Health Preparedness
- Survival rate in hypertensive patients with COVID-19
- (2020) Amir Emami et al. CLINICAL AND EXPERIMENTAL HYPERTENSION
- The Two Faces of ACE2: The Role of ACE2 Receptor and Its Polymorphisms in Hypertension and COVID-19
- (2020) Mira Bosso et al. Molecular Therapy-Methods & Clinical Development
- Quality assessment of observational studies in a drug-safety systematic review, comparison of two tools: the Newcastle–Ottawa Scale and the RTI item bank
- (2014) Andrea V Margulis et al. Clinical Epidemiology
- Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes
- (2009) Jin-Kui Yang et al. ACTA DIABETOLOGICA
- A systematic review of integrated use of disease-management interventions in asthma and COPD
- (2009) Karin M.M. Lemmens et al. RESPIRATORY MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started